Small and Intermediate Calcium-Activated Potassium Channel Openers Improve Rat Endothelial and Erectile Function
Open Access
- 20 September 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 8, 660
Abstract
Modulation of endothelial calcium-activated potassium (KCa) channels has been proposed as an approach to restore endothelial function. The present study investigated whether novel openers of KCa channels with small (KCa2.x) and intermediate (KCa3.1) conductance, NS309 and NS4591, improve endothelium-dependent relaxation and erectile function. Rat corpus cavernosum (CC) strips were mounted for isometric tension recording and processed for immunoblotting. Mean arterial pressure (MAP), intracavernosal pressure (ICP), and electrocardiographic (ECG) measurements were conducted in anaesthetized rats. Immunoblotting revealed the presence of KCa2.3 and large KCa conductance (KCa1.1) channels in the corpus cavernosum. NS309 and NS4591 increased current in CC endothelial cells in whole cell patch clamp experiments. Relaxation induced by NS309 (<1 µM) was inhibited by endothelial cell removal and high extracellular potassium. An inhibitor of nitric oxide (NO) synthase, and blockers of KCa2.x and KCa1.1 channels, apamin and iberiotoxin also inhibited NS309 relaxation. Incubation with NS309 (0.5 µM) markedly enhanced acetylcholine relaxation. Basal erectile function (ICP/MAP) increased during administration of NS309. Increases in ICP/MAP after cavernous nerve stimulation with NS309 were unchanged, whereas NS4591 significantly improved erectile function. Administration of NS309 and NS4591 caused small changes in the electrocardiogram, but neither arrhythmic events nor prolongation of the QTc interval were observed. The present study suggests that openers of KCa2.x and KCa3.1 channels improve endothelial and erectile function. The effects of NS309 and NS4591 on heart rate and ECG are small, but will require additional safety studies before evaluating whether activation of KCa2.3 channels has a potential for treatment of erectile dysfunction.Keywords
Funding Information
- Aarhus Universitet
- Consejo de Desarrollo Científico y Humanístico, Universidad Central de Venezuela
- Hjerteforeningen
- Novo Nordisk
- Carlsbergfondet (2013_01_0438)
This publication has 53 references indexed in Scilit:
- Flow-Evoked Vasodilation is Blunted in Penile Arteries from Zucker Diabetic Fatty RatsThe Journal of Sexual Medicine, 2012
- Opening of Small and Intermediate Calcium-Activated Potassium Channels Induces Relaxation Mainly Mediated by Nitric-Oxide Release in Large Arteries and Endothelium-Derived Hyperpolarizing Factor in Small Arteries from RatThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogsBritish Journal of Pharmacology, 2011
- Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca 2+ -Activated K + Channel InhibitionHypertension, 2011
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Openers of small conductance calcium‐activated potassium channels selectively enhance NO‐mediated bradykinin vasodilatation in porcine retinal arteriolesBritish Journal of Pharmacology, 2010
- NS309 restores EDHF‐type relaxation in mesenteric small arteries from type 2 diabetic ZDF ratsBritish Journal of Pharmacology, 2010
- NS11021, a novel opener of large‐conductance Ca2+‐activated K+channels, enhances erectile responses in ratsBritish Journal of Pharmacology, 2009
- Combination of Ca2+‐activated K+ channel blockers inhibits acetylcholine‐evoked nitric oxide release in rat superior mesenteric arteryBritish Journal of Pharmacology, 2006
- Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHFBiochemical and Biophysical Research Communications, 2003